
What is Multiple Myeloma?
Multiple myeloma is a cancer of plasma cells - a type of white blood cell found in bone marrow.
Overview
Multiple myeloma is a cancer of the plasma cells in the bone marrow. Plasma cells normally produce antibodies that help the body fight infection. In multiple myeloma, abnormal plasma cells grow uncontrollably and produce ineffective antibodies while crowding out healthy blood cells. As these myeloma cells accumulate, they can damage bones, weaken the immune system, and affect other organs throughout the body.
(add how it develops, how it impacts the body- add stats)
Myeloma Cells Activate Bone Destruction -Healthy bones are maintained through a balance between cells that remove old bone and cells that build new bone. Multiple myeloma disrupts this balance by stimulating bone-destroying cells called osteoclasts. As a result, bone is broken down faster than it can be replaced, leading to areas of weakness and damage throughout the skeleton.
Bone Damage Can Lead to Pain and Fractures - As bone tissue deteriorates, small holes known as lytic lesions can develop within the bones. These weakened areas may cause persistent bone pain, tenderness, and reduced mobility. Over time, bones become more fragile and are at greater risk for fractures, even during normal daily activities. Many patients also develop osteoporosis, a condition that further decreases bone strength and increases fracture risk.
Common Areas Affected - Multiple myeloma most commonly affects bones that contain large amounts of active bone marrow. Frequently affected areas include the spine, ribs, hips, skull, pelvis, and long bones of the arms and legs. Bone pain in the back, ribs, or hips is often one of the earliest symptoms that leads patients to seek medical attention.

Symptoms
xxx
.png)
xxx
xx
xxxx

xxx
xxx
xxxxx

xxx
xxx
xxxx

Diagnosis
Treatment
xxxx
Support the Mission
Every donation helps extend the reach of the Foundation's mission and supports organizations working to improve lives, strengthen communities, and accelerate multiple myeloma research.

